BioLargo, Inc., based in Westminster, California, has announced the installation of its Aqueous Electrostatic Concentrator (AEC) PFAS treatment system at the municipal water facility in Lake Stockholm, New Jersey. This innovative system is designed to improve the quality of drinking water in the area by effectively removing both long- and short-chain PFAS contaminants, which are traditionally difficult for standard treatment technologies to eliminate.
Once the facility completes its commissioning process, the AEC system is expected to provide Lake Stockholm residents with drinking water that adheres to the stricter standards set by both the Environmental Protection Agency (EPA) and the state of New Jersey. BioLargo’s CEO, Dennis Calvert, emphasized the significance of this installation, stating it marks a major step for the company in deploying their technology at a municipal level.
The AEC technology presents several advantages over conventional PFAS treatment methods. Notably, it generates minimal waste, addressing environmental concerns that arise from traditional systems which often leave behind substantial contaminated residue. This characteristic is especially beneficial for Lake Stockholm, where local disposal options are limited.
The system will be closely monitored over the next year by the New Jersey Department of Environmental Protection (NJDEP) and the EPA. This extensive oversight includes regular testing of PFAS chemicals to ensure compliance with drinking water standards. Data collected during this period will support ongoing regulatory requirements and confirm the system's readiness for sustained use.
As noted by Tonya Chandler, President of BioLargo Equipment, Solutions and Technologies, Inc., the successful implementation of the AEC system could significantly enhance the company's reputation in the industry. Should the technology prove effective, it may open up numerous opportunities for BioLargo in New Jersey and beyond, as municipalities increasingly seek sustainable solutions for PFAS contamination.
BioLargo's installation of the Aqueous Electrostatic Concentrator (AEC) in Lake Stockholm marks a pivotal moment for the company as it transitions its technology into actual municipal applications. This initiative is expected to enhance local drinking water quality by meeting stringent regulatory standards.
The AEC technology differs from conventional methods by effectively targeting both long- and short-chain PFAS compounds, which are often challenging to remove with standard treatment solutions. Additionally, the AEC produces minimal waste, addressing a common environmental concern associated with traditional systems.
The Lake Stockholm community is set to benefit significantly from improved drinking water quality. The AEC is designed to bring PFAS levels below both state and federal standards, directly impacting public health and safety.
The New Jersey Department of Environmental Protection (NJDEP) and the U.S. Environmental Protection Agency (EPA) will oversee the AEC system’s performance through ongoing testing and regulatory compliance. This relationship reinforces the credibility of BioLargo's technology and its commitment to public health.
The successful implementation of the AEC system in Lake Stockholm is likely to create additional opportunities for BioLargo, potentially leading to similar installations in other regions. The technology's scalability positions the company favourably in the growing market for sustainable water treatment solutions.
The 12-month monitoring period will include regular testing of PFAS chemicals by the NJDEP to ensure compliance with drinking water standards. This data will not only provide reassurance regarding the system's efficacy but also help establish AEC as a market leader in PFAS treatment technology.
Future opportunities for the AEC technology may include partnerships with other municipalities and expansions into additional markets, particularly as awareness of PFAS contamination increases and demands for innovative treatment solutions grow.
BioLargo plans to expand its commercial reach by licensing its technologies and establishing channel partnerships. This approach is designed to maximise the impact of their innovations, particularly in addressing the pressing issues of water contamination.